Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces by Aninwene, George E et al.
© 2008 Aninwene et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2008:3(2) 257–264 257
ORIGINAL RESEARCH
Enhanced osteoblast adhesion to drug-coated 
anodized nanotubular titanium surfaces
George E Aninwene II1
Chang Yao2
Thomas J Webster2
1Department of Biochemical 
Engineering, University of Maryland, 
Baltimore, MD; 2Division of 
Engineering, Brown University, 
Providence, RI, USA
Correspondence: Thomas J Webster
Divisions of Engineering and Orthopedics, 
Brown University, Providence, RI 02917, 
USA
Tel +1 401 863 2318
Fax +1 401 863 1007
Email thomas_webster@brown.edu
Abstract: Current orthopedic implants have functional lifetimes of only 10–15 years due to a 
variety of reasons including infection, extensive inﬂ  ammation, and overall poor osseointegration 
(or a lack of prolonged bonding of the implant to juxtaposed bone). To improve properties of 
titanium for orthopedic applications, this study anodized and subsequently coated titanium with 
drugs known to reduce infection (penicillin/streptomycin) and inﬂ  ammation (dexamethasone) 
using simple physical adsorption and the deposition of such drugs from simulated body ﬂ  uid 
(SBF). Results showed improved drug elution from anodized nanotubular titanium when drugs 
were coated in the presence of SBF for up to 3 days. For the ﬁ  rst time, results also showed that 
the simple physical adsorption of both penicillin/streptomycin and dexamethasone on anod-
ized nanotubular titanium improved osteoblast numbers after 2 days of culture compared to 
uncoated unanodized titanium. In addition, results showed that depositing such drugs in SBF 
on anodized titanium was a more efﬁ  cient method to promote osteoblast numbers compared to 
physical adsorption for up to 2 days of culture. In addition, osteoblast numbers increased on 
anodized titanium coated with drugs in SBF for up to 2 days of culture compared to unanod-
ized titanium. In summary, compared to unanodized titanium, this preliminary study provided 
unexpected evidence of greater osteoblast numbers on anodized titanium coated with either 
penicillin/streptomycin or dexamethasone using simple physical adsorption or when coated 
with SBF; results which suggest the need for further research on anodized titanium orthopedic 
implants possessing drug-eluting nanotubes.
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Introduction
The skeletal system is integral for all physical functions in the body. However, many 
individuals ﬁ  nd themselves in a state where one or more of their bones are no longer 
able to support physiological loading. This may be due to osteoporosis, severe bone 
damage, bone fracture, or a variety of other osteopathic problems. When bone is irrepa-
rably damaged, an implant is required to fasten, support, regrow, or replace existing 
bone. Titanium and titanium alloys are commonly used as orthopedic implants due to 
their high mechanical strength, low weight, and bio-inertness. Their bio-inertness is 
the result of a nonreactive titanium oxide layer that spontaneously forms in the body 
on the titanium surface. This is beneﬁ  cial because the oxide layer is biocompatible 
and keeps the implant from degrading under harsh conditions within the human body 
(Brunette et al 2000).
Although titanium meets many, if not all, of the requirements to be a successful 
orthopedic implant material, current titanium implants have long-term failure rates due 
to a variety of reasons including infection, incomplete acceptance of these foreign mate-
rials in the body leading to excessive inﬂ  ammation, and poor bonding with juxtaposed 
bone (that is, poor osseointegration). When any synthetic orthopedic implant is placed 
in the body, a series of immune system responses are initiated, sometimes resulting International Journal of Nanomedicine 2008:3(2) 258
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in prolonged soft (instead of hard) tissue encapsulation. 
This soft tissue encapsulation causes deleterious wear and 
abrasion. As a result, titanium orthopedic implants have an 
average lifetime of only about 10–15 years before they have 
to be replaced (Yao et al 2005).
Decreasing infection, reducing inflammation, and 
increasing bone growth on titanium surfaces are needed in 
order to lengthen the lifetime of titanium implants. These 
events will securely fasten the implant into the juxtaposed 
bone. There have been many attempts to improve currently-
used titanium for orthopedic applications. It has already 
been proven that anodizing titanium promotes in vitro 
bone growth compared to unanodized titanium (Yao et al 
2005). If controlled properly, the anodization process cre-
ates titania (ie, titanium dioxide) nanotubes on the surface 
of titanium (the mechanism by which nanotubes form is 
described elsewhere (Raja et al 2005) and it is brieﬂ  y shown 
in Figure 1). These anodized nanotubes increase the rough-
ness of titanium surfaces on the nanoscale and, thus, allow 
titanium to become more similar to the natural roughness 
of human bone. Bone-forming cells, or osteoblasts, tend 
to adhere to surfaces that are similar (both in chemistry 
and roughness) to natural bone, thus, anodization is a 
logical biologically-inspired method to promote osteoblast 
functions (Yao et al 2005).
Moreover, the nanotubes anodized on the titanium surface 
can serve as reservoirs for drugs small enough to ﬁ  t inside 
these tubes. Through anodization, conventional nondrug-
loaded titanium can be transformed into novel drug-eluting 
titanium. One can even envision spatial loading of anti-
infection, anti-inﬂ  ammatory, and pro-bone growth drugs to 
further improve orthopedic implant efﬁ  cacy. Accordingly, 
a longer drug release proﬁ  le can hopefully be established 
through the use of anodized nanotubular titanium to com-
pensate for the variety of current orthopedic implant failure 
modes. However, although physical adsorption is the easi-
est and most direct way to load drugs into porous anodized 
titanium substrates, there may be surface tension problems 
that inhibit drug loading. Thus, the speciﬁ  c goals of this in 
vitro study were to determine drug elution from and osteo-
blast densities on anodized nanotubular titanium coated with 
penicillin/streptomycin (anti-infection drugs) and dexameth-
asone (an anti-inﬂ  ammatory drug) using physical adsorption 
compared to a novel manner to load drugs (through the use 
of simulated body ﬂ  uid or SBF). Speciﬁ  cally, an alternative 
to physical adsorption is to simultaneously coat titanium 
Figure 1 Separation of nanopores to form an individual nanotubular oxide layer during anodization of titanium. (a) Formation of individual nanotubes during anodization, 
(b) side view of the nanotubes after anodization and the (c) schematic illustration of the pore separation mechanism. Cation vacancies generated by the dissolution of Ti cations 
are transported radially from the two sides of the common wall of the neighbor pores. Charges of similar polarity repel and when electrical neutrality is not maintained this 
repulsion causes separation of pores into individual nanotubes as seen in (b). Copyright © 2005. Adapted with permission from Raja KS, Misra M, Paramguru K. 2005. Formation 
of self-ordered nano-tubular structures of anodic oxide layer on titanium. Electrochimica Acta, 51:154–65.International Journal of Nanomedicine 2008:3(2) 259
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nanotubes with calcium phosphate crystals that form on 
titanium when soaked in simulated body ﬂ  uid (SBF) and 
drugs (Oh et al 2005). Such calcium phosphate crystals may 
provide optimal surface energy for the efﬁ  cient coverage of 
anodized nanotubular titanium with drugs.
Materials and methods
Titanium anodization
The anodization procedure followed in this study is shown 
in Figure 2. Speciﬁ  cally, titanium (99.8% pure; Alfa Aesar, 
Ward Hill, MA, USA) was cut to the desired size (1 cm × 
1 cm × 2 mm). Just prior to anodization, each titanium 
sample was soaked in a dilute nitric acid and hydroﬂ  uoric 
acid solution for approximately 2 minutes. Titanium was then 
removed and rinsed with deionized water. Next, the sample 
was used as an anode in an electrochemical cell, parallel to 
a platinum mesh acting as the cathode (step 3 in Figure 2). 
The 1.5% hydroﬂ  uoric acid solution served as an electrolyte 
solution and completed the circuit. A constant voltage of 20 
V was then applied to the circuit for 10 minutes. After that, 
the samples were once again rinsed with deionized water.
After the anodization process, titanium was soaked 
in a 70% ethanol solution for at least 10 minutes. The 
submerged samples were then placed in a sonicator (VWR, 
West Chester, PA, USA; 10W) for 10 minutes, rinsed and 
then soaked in deionized water for 2 minutes, and dried in 
an oven. Once dry, titanium was sterilized by autoclaving 
(120 °C). Unanodized titanium was cleaned and sterilized 
using the same process.
Drug coating: Simple physical adsorption
Two approaches were used in this study to coat titanium with 
drugs: simple physical adsorption and coating with simulated 
body ﬂ  uid (SBF). For simple physical adsorption, 120 µl of 
either penicillin/streptomycin (Hyclone, Logan, UT, USA; 
5 µg/ml) or dexamethasone (Sigma, St. Louis, MO, USA; 
5 µg/ml) solutions were placed onto each unanodized or 
anodized titanium for 3 days at room temperature. The 
samples were then rinsed with phosphate buffered saline 
(PBS) to remove excess proteins.
Drug coating: Soaking in simulated body 
ﬂ  uid (SBF)
For the second approach, after titanium cleaning and ster-
ilization as described above, titanium samples were soaked 
in a 6.0 M sodium hydroxide for approximately 1 hour. The 
samples were then removed and placed in a furnace at 500 °C 
for approximately 2 hours. After this, titanium was allowed 
to cool to room temperature in air. Titanium was then soaked 
in a 1.5X SBF (Sigma) solution (controls) or either a mixture 
of 1.5X SBF and penicillin/streptomycin or dexamethasone 
for 3 days at room temperature. The same concentrations of 
Figure 2 Schematic of the anodization process.
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penicillin/streptomycin and dexamethasone were used in SBF 
coatings as in the simple physical adsorption method.
Material characterization
Before and after coating titanium with drugs, they were 
visualized with scanning electron microscopy according to 
standard techniques (Yao et al 2005).
Drug elution assay
To assess the elution of drugs (speciﬁ  cally, penicillin/strep-
tomycin and dexamethasone) into the supernatant solution, 
substrates were placed in 12 well plates with 2 ml of protein-
free Dulbecco’s Modiﬁ  ed Eagle’s Medium (DMEM; Gibco, 
Grand Island, NY, USA) under standard cell culture condi-
tions for up to 3 days. After 1, 2, and 3 days, 10 µl of the 
supernatant solution was removed from each well and tested 
for protein content using the commercially available BCA 
(Pierce, Rockford, IL, USA) kit and a spectrophotometer. 
Values were compared to a standard curve to determine 
speciﬁ  c protein concentration (µg/ml).
Osteoblast density assay
Osteoblasts (ATCC, USA; CRL 1221) were seeded (3,500 
cells/cm2) in DMEM (Gibco) supplemented with 10% fetal 
bovine serum (Hyclone) and 1% penicillin/streptomycin 
(Hyclone) onto the substrates of interest to the present study 
under standard conditions. Osteoblasts were then cultured for 
up to 2 days. After incubation, the samples were rinsed with 
PBS to remove nonadherent cells and the adherent cells were 
ﬁ  xed using formaldehyde, stained with a DAPI ﬂ  orescent dye 
(Molecular Probes, Eugen, OR, USA), and counted using 
ﬂ  uorescence microscopy.
Statistical analysis
All experiments were conducted in triplicate and repeated 
at three different times. Differences between means were 
assessed using student t-tests at a signiﬁ  cance value of 
p  0.1.
Results
Material characterization
As expected, results of this study demonstrated that 
anodized titanium possessed highly ordered nanotubes 
whereas unanodized titanium did not (Figure 3); this 
conﬁ  rms results from other studies (Yao et al 2005). As 
observed from the scanning electron microscope images, 
the average size of the anodized nanotubes in titanium 
was approximately 60 nm in diameter. Results of this 
study also provided evidence that drugs (speciﬁ  cally, 
penicillin/streptomycin and dexamethasone) were coated 
Figure 3 Scanning electron microscope images of unanodized titanium (left) and anodized nanotubular titanium (right).International Journal of Nanomedicine 2008:3(2) 261
Enhanced osteoblast adhesion 
on the titanium substrates after simple physical adsorption 
(as an example, penicillin/streptomycin is shown adsorbed 
on anodized nanotubular titanium in Figure 4). In addition, 
scanning electron micrographs provided evidence of drug 
coatings in the presence of SBF on titanium substrates (as 
an example, penicillin/streptomycin is shown adsorbed 
on anodized titanium in the presence of SBF in Figure 5). 
Importantly, while the underlying anodized titanium nano-
pores were visible through the simple physical adsorption 
of drugs, no underlying nanopores were observed when 
drugs were coated in the presence of SBF (comparing 
Figures 4 and 5).
Drug elution
Results of the present study provided evidence of improved 
prolonged release of both penicillin/streptomycin and 
dexamethasone from anodized titanium when coated in the 
presence of SBF compared to simple physical adsorption 
(Figure 6). In fact, after 3 days, 3 times more penicillin/
streptomycin was released from anodized titanium coated 
in the presence of SBF compared to the physical adsorption 
method. Such results may be related to the previous scanning 
electron micrographs demonstrating an improved coating of 
the underlying anodized nanotubes through the use of drugs 
in SBF compared to simple physical adsorption. In fact, from 
Figure 6, one can ascertain that in total 2.76 µg of penicillin/
streptomycin and 2.3 µg of dexamethasone were released from 
the anodized titanium surfaces when using simple physical 
adsorption while 3.3 µg of penicillin/streptomycin and 2.6 µg 
of dexamethasone were released from the anodized titanium 
surfaces when coated in the presence of SBF. Thus, the results 
of the present study suggest that more penicillin/streptomycin 
and dexamethasone can be incorporated into anodized 
titanium when coated in the presence of SBF.
Osteoblast adhesion
Not surprisingly, results of this study conﬁ  rmed previous 
studies which have reported greater osteoblast numbers on 
Figure 4 Scanning electron microscope images of penicillin/streptomycin coated on anodized titanium using simple physical adsorption (left: scale bar = 3 µm; right: scale 
bar = 200 nm). These images are separate ﬁ  elds of view on the same substrate.
Figure 5 Scanning electron microscope images of anodized titanium alone (left) and when coated with penicillin/streptomycin in simulated body ﬂ  uid (right). Scale bars = 200 nm.
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anodized compared to unanodized titanium (Figure 7) (Yao 
et al 2005). However, surprisingly, results of the present 
study also demonstrated improved osteoblast numbers after 
2 days of culture on drug-coated anodized titanium samples 
(whether by simple physical adsorption or through the use of 
SBF) compared to unanodized titanium. In addition, greater 
osteoblast numbers where observed on anodized nanotubular 
titanium coated with drugs in SBF compared to the physical 
adsorption method. Osteoblast numbers were similar on all 
substrates of interest after 1 day of culture.
Discussion
Orthopedic implant failures have been correlated to infec-
tion, extensive inﬂ  ammation, and poor osseointegration 
into juxtaposed bone. While there have been many efforts 
to improve osteoblast functions on titanium by modifying 
its surface properties, little effort has been dedicated to 
combining drug delivery with current orthopedic implants to 
ﬁ  ght infection and extensive inﬂ  ammation. For this reason, 
titanium which possesses numerous nanotubes may serve 
as reservoirs for such drugs for their controlled prolonged 
release. Anodization, under the correct parameters (such 
as electrolyte solution, voltage, and time) can transform 
currently-used titanium into titanium which possesses nano-
tubes. Previous studies have shown that uncoated anodized 
nanotubular titanium promotes osteoblast functions since it 
initially adsorbs greater amounts of vitronectin (a key protein 
that mediates osteoblast adhesion) from serum than unanod-
ized titanium (Yao et al 2005). However, to determine the 
efﬁ  cacy of such anodized nanotubular titanium for orthopedic 
applications involving drug delivery, the objective of this in 
vitro study was to determine an effective method for loading 
drugs into anodized titanium and then to determine osteoblast 
densities on such substrates.
In this manner, physical adsorption is the easiest and 
most direct way to load drugs into porous anodized titanium 
Figure 6 Drug elution from titanium after 1, 2, and 3 days.
Abbreviations: A + PS, anodized + penicillin/streptomycin physical adsorption; A + DEXA, anodized + dexamethasone physical adsorption; ASH + PS, anodized, heat-treated 
and SBF-soaked titanium + penicillin/streptomycin; ASH + DEXA, anodized, heat-treated and SBF-soaked titanium + dexamethasone; SBF, simulated body ﬂ  uid.
Notes: Data = mean ± SEM; N = 3; *p  0.1 compared to respectively coated drug using physical adsorption.
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substrates. However, since anodized titanium possesses 
nanotubes, there may be surface tension problems that 
inhibit drug loading. For this reason, we investigated an 
additional manner to load drugs into anodized nanotubular 
titanium. Speciﬁ  cally, an alternative to physical adsorption 
is to simultaneously coat titanium nanotubes with calcium 
phosphate crystals that form on titanium when soaked in SBF 
and drugs (Oh et al 2005). Such calcium phosphate crystals 
may provide optimal surface energy for the efﬁ  cient cover-
age of anodized nanotubular titanium with drugs. Additional 
advantages of using SBF during the coating process is that it 
forms a highly cytocompatible surface for bone cells and its 
degradation rate can be tailored by varying parameters such as 
coating thickness. Results from this study provided evidence 
of a more prolonged release of penicillin/streptomycin and 
dexamethasone and better osteoblast densities when anod-
ized nanotubular titanium was coated with SBF compared 
to simple physical adsorption.
Importantly, penicillin/streptomycin and dexametha-
sone were used as model drugs in this study. Penicillin and 
streptomycin have long been used as antibacterial drugs. 
To the best of the authors’ knowledge, this is the ﬁ  rst time 
that improved osteoblast functions have been reported when 
using penicillin/streptomycin drug release. Dexamethasone 
is a potent member of the glucocorticoid class of steroid 
hormones and acts as an anti-inﬂ  ammatory and immunosup-
pressant. Dexamethasone decreases ﬁ  brous tissue formation 
resulting from excessive foreign body responses, promotes 
osteoblast differentiation, and potentially increases new 
bone formation (Mori et al 1999). Since each drug has its 
limitations, they were used here only as model drugs. It is 
envisioned that other drugs perhaps with less detrimental 
side effects and of similar size could also be loaded into 
the anodized nanotubular titanium to improve orthopedic 
implant efﬁ  cacy.
Conclusions
This study highlighted the initial promise of utilizing anod-
ized nanotubular titanium as a novel drug-eluting orthope-
dic implant. By using simple physical adsorption of drugs 
(speciﬁ  cally, penicillin/streptomycin and dexamethasone), 
improved osteoblast densities were observed compared to 
unanodized uncoated titanium. Moreover, improved pro-
longed drug release (up to 3 days) and osteoblast densities 
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Figure 7 Osteoblast numbers after 1 and 2 days of culture.
Abbreviations: U, unanodized Ti; A, anodized Ti alone; A + PS, anodized + penicillin/streptomycin physical adsorption; Anodized + DEXA, anodized + dexamethasone physi-
cal adsorption; ASH, anodized, heat-treated and SBF-soaked Ti; ASH + PS, ASH + penicillin/streptomycin; ASH + DEXA, ASH + dexamethasone; SBF, simulated body ﬂ  uid.
Notes: Data = Mean + SEM; N = 3; *p  0.1 compared to unanodized titanium; **p  0.1 compared to respectively coated drug using physical adsorption.International Journal of Nanomedicine 2008:3(2) 264
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(up to 2 days) were observed when anodized nanotubular 
titanium was coated with drugs in the presence of SBF 
compared to drugs coated using simple physical adsorption. 
In this manner, although more investigation is needed, this 
study indicates that anodized nanotubular titanium may hold 
promise as both a drug eluting orthopedic implant to reduce 
infection and inﬂ  ammation while promoting bone growth.
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